GP 48989

structure

Also Known As:

GP-48989; 5-methyl-3-(2-methylallyl)-2-((3-methyl-4-oxo- 2-thiazolidinylidene)hydrazono)-4-thiazolidinone

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/01/1976 - "The effect of GP 48989 (5-methyl-3-(2-methylallyl)-2- ((3-methyl-4-oxo-2-thiazolidinylidene)hydrazono)-4- thiazolidinone) on the regression of "hormone-independent" DMBA-induced mammary tumors in rats and on estradiol receptors was studied. "
2.	Carcinoma (Carcinomatosis) 01/01/1976 - "Regression of "hormone-independent" DMBA-induced mammary carcinomas in response to GP 48989 and its effects on hormone receptors."

1.	Estradiol Receptors (Estradiol Receptor)
2.	Hormones (Hormone)